Metabolic reprogramming has emerged as a attractive strategy in the fight against cancer. Tumors often exhibit altered metabolic pathways to support their rapid growth and survival. By targeting these aberrant metabolic processes, researchers aim to disrupt tumor progression and enhance therapeutic efficacy. One promising approach involves manipul